newsfilter
← Latest News
GlobeNewswire·

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

  • ENvue Medical, Inc. (NASDAQ: FEED) entered a securities purchase agreement ("ELOC") providing an equity facility of up to $50 million.
  • The facility is subject to terms including the receipt of stockholder approval.
  • Capital will support advancing the next-generation technology platform & evaluating selective strategic acquisitions.
  • Near-term priorities include accelerating adoption of the ENvue feeding tube navigation system & expanding its installed hospital base.
  • The Company plans to increase utilization & recurring revenue across existing accounts while advancing AI & automation technologies.
  • ENvue aims to improve operating efficiency, maintain disciplined capital allocation, & pursue accretive acquisitions to expand its product portfolio.
  • The ENvue™ Navigation Platform is FDA 510(k) cleared for adult enteral care & may expand to pediatric & vascular applications.
  • Acoustic-based therapeutic technologies PainShield® & UroShield® utilize proprietary SAW technology to treat pain & disrupt biofilms in home or care settings.
  • The Company is headquartered in Tyler, Texas, with R&D in Tel-Aviv, Israel, & manufacturing operations in the United States.